Research programme: metabotropic glutamate receptor antagonists - Schering-Plough
Latest Information Update: 30 Nov 2009
At a glance
- Originator Schering-Plough
- Class Imidazoles; Indoles; Morpholines
- Mechanism of Action Metabotropic glutamate receptor type 1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 23 Aug 2007 Preclinical trials in Pain in USA (PO)